Anika Therapeutics Inc. Common Stock (NASDAQ: ANIK) last traded at $13.40, down 2.97% on the session. The quote above updates while this page is open; the figures below are drawn from Anika Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Anika Therapeutics Inc. Common Stock trades on NASDAQ under the ticker ANIK. Its market capitalisation is $179.50 million.
Valuation measures for Anika Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $179.50M |
|---|---|
| Enterprise value | $186.56M |
| Price / sales | 1.45 |
| Price / book | 1.30 |
| Beta | 0.69 |
Trailing-twelve-month figures tagged in Anika Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $123.43M |
|---|---|
| Net income (TTM) | -$1.77M |
| EPS (TTM) | -$0.130 |
| Gross margin | 63.40% |
| Operating margin | -2.11% |
| Return on equity | -1.28% |
| Cash | $44.96M |
Range and volume for ANIK over the past 52 weeks.
| 52-week high | $22.88 |
|---|---|
| 52-week low | $9.01 |
| Volume | 87.8K |
| Average volume | 106.3K |
| Previous close | $13.81 |
Invest a chosen dollar amount in Anika Therapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ANIK.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.